Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_assertion type Assertion NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_head.
- NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_assertion description "[We document an EGFR mutation in a patient with papillary renal cell cancer with a history of multiple therapies, including interferon-alpha, interleukin-2, 5-fluorouracil, and interferon-alpha together with 13-cis-retinoic acid, to which floxuridine was later added, and thalidomide maintenance therapy for six years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance.
- NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_assertion evidence source_evidence_literature NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance.
- NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_assertion SIO_000772 20346742 NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance.
- NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_assertion wasDerivedFrom befree-2016 NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance.
- NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_assertion wasGeneratedBy ECO_0000203 NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance.